
Vineet Laboratories Ltd is Rated Hold by MarketsMOJO
2026-11-01 10:10:46Vineet Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 October 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreVineet Laboratories Gains 4.36%: 2 Key Factors Driving the Week
2026-10-31 12:02:32Key Events This Week 26 Oct: Stock opens at Rs.36.50, up 2.67% 28 Oct: Positive financial trend reported amid mixed quarterly performance 29 Oct: Stock surges 3.84% following valuation upgrade 30 Oct: Valuation shifts signal changing market sentiment Week OpenRs.35.55 Week CloseRs.37.10<d...
Read More
Vineet Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment
2026-10-30 08:03:13Vineet Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer averages to assess the stock’s current price attractiveness.
Read More
Vineet Laboratories Ltd Reports Positive Financial Trend Amid Mixed Quarterly Performance
2026-10-28 08:00:18Vineet Laboratories Ltd has demonstrated a notable shift in its financial trajectory, upgrading its performance trend from flat to positive in the latest quarter ending June 2026. Despite a mixed bag of results, including a significant dip in quarterly net sales, the company’s overall financial health shows encouraging signs of recovery and operational efficiency improvements.
Read More
Vineet Laboratories Ltd Valuation Shifts Signal Improved Price Attractiveness Amid Mixed Returns
2026-10-23 08:03:19Vineet Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a more attractive price point for investors despite ongoing operational challenges. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for shareholders and potential investors.
Read More
Vineet Laboratories Ltd is Rated Sell
2026-10-21 10:10:02Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 October 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Vineet Laboratories Ltd is Rated Sell
2026-10-10 10:10:05Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Vineet Laboratories Ltd Valuation Shifts Signal Improved Price Attractiveness
2026-10-06 08:02:55Vineet Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting evolving investor perceptions amid mixed financial performance and sector dynamics. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to assess the stock’s price attractiveness.
Read More
Vineet Laboratories Ltd is Rated Sell
2026-09-29 10:10:03Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreIntimation-Newspaper Publication Of Financial Results For The Quarter Ended 30.09.2026
16-Nov-2026 | Source : BSEIntimation-Newspaper publication of finaancial results of the quarter and half year ended 30.09.2026.
Statement Of Deviation & Variation For September 30 2026
13-Nov-2026 | Source : BSEStatement of Deviation & Variation for September 30 2026 quarter
Board Meeting Outcome for Results For The Quarter And Half Year Ended 30.09.2026
12-Nov-2026 | Source : BSEResults for the quarter and half year ended 30.09.2026
Corporate Actions
No Upcoming Board Meetings
Vineet Laboratories Ltd has declared 10% dividend, ex-date: 19 Sep 22
No Splits history available
No Bonus history available
No Rights history available